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Abstract
Intro: Systemic Lupus Erythematosus (SLE) is a multisystem inflammatory autoimmune disease
that affects more than a quarter million people in the United States today. It involves a
dysfunction within the humoral immune systems that leads the body to attack its own tissues
mediating a chronic disease comprising episodes of exacerbations and remissions in which
severe complications may occur.
Background: Although the exact etiology of SLE is unknown, previous research has implicated a
multitude of etiological components associated with SLE including genetic, hormonal,
immunologic and environmental influences. In fact, research has found the development of SLE
dependent upon the interaction of these components. The current literature review seeks to
examine the underlying patterns and interactions of etiological components that contribute to the
development of SLE.
Methods: The following databases were used in completing searches: Google, Scholar, Pub Med
(n=9), Europe PMC (n=8) and Wiley Online Library (n=2). Additionally, ancestry searches were
used to locate articles (n=8).
Results: Various factors were identified under each etiological category contributing to SLE.
There is a prominent gene-environmental interaction that often triggers the disease and the
hormonal-gene and gene-immunologic interactions are more often thought to progress the
disease leading to further dysfunction of the immune system.
Discussion: These results highlight the complexity and need of etiological interactions for SLE
to develop. Despite the varying ways for the disease to begin, identification of susceptible genes
for targeted gene therapy could lower the risk of SLE development. Further research is necessary
to identify etiological components and corroborate the extent of interaction for SLE to develop.
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Introduction
According to the Centers for Disease Control and Prevention ([CDC], 2018), SLE affects
approximately 1 in every 2000 persons which amounts to relatively 250,000 to 350,000 people in
the United States. SLE primarily presents in women during the reproductive age with a ratio of
90 women to 10 men. The interaction of the identified four etiological categories-hormones,
genes, immunology, and environment- results in a large production of autoantibodies or
antibodies against self-antigens, as well as immune complexes, which target all organ systems in
the body (Huether & McCance, 2016). The wide selection of targeted tissues and cellular
components enables numerous and diverse manifestations such as stroke, glomerulonephritis,
leukopenia, alopecia or reproductive abnormalities. Complications alike these cause drastic, long
term altercations in quality of life emotionally and physically (Huether & McCance) (Lewis et.al.
2017). While treatments are available, many are inadequate (Gough & Simmonds, 2007). Due to
the severity of this disease process, lack of cure and effective treatments, understanding the
etiology, prophylactic interventions and therapy are a necessity (Gough & Simmonds, 2007).
Further research is necessary to corroborate each etiological component and its role in the
development of SLE. More specifically, limited work has examined the patterns of etiologic
components that trigger the production of defective antibodies and hence SLE. With
identification of these patterns, there is greater potential for prophylactic therapies to evolve.
Therefore, the current literature review seeks to investigate underlying etiological components
and interactional patterns contributing to the development of SLE.
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Methodology
In identifying studies to be included in this literature review, articles/studies related to the
subject of interest were examined. The following databases and search engines have been used in
completing searches: Medline, PubMed, Nursing Reference Center Plus, Google, Scholar, ,
Europe PMC and Wiley Online Library (n=2). Additionally, ancestry searches were used to
locate articles (n=8). Additional information was sought from Health Source: Nursing/Academic
Edition. Ancestry and Key phrase searches were methods utilized to locate the intended articles.
Criteria for article selection were evaluated upon citations, publisher/author, and subject
relevance and content.
Review of Literature
Genetic Influences
The study by Molokhia and McKeigue (2005) reported that risk for SLE increases with
specific ethic origins. The prevalence of general lupus was found to be higher within AfricanAmerican, Afro-Caribbean, Native American, Asian Indian, Polynesian and Chinese populations
in comparison to populations of primarily European descent. The consistent higher prevalence of
lupus in these ethnic populations despite their living in different environments supports the
conclusion that genetic factors are involved within the pathology of SLE. The specific genes or
genetic factors that increase risk through ethnicity have not been identified nor related to varying
allele frequencies known to be associated with SLE risk.
One genetic factor that has been identified involves the HLA region, more specifically
the HLA-DR2 and HLA-DR3 genes. As discussed by Gough & Simmonds (2007), the HLA
region has been strongly associated or correlated with autoimmune diseases for approximately
fifty years now. It is responsible for encoding cellular components and molecules that have
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significant roles in the immune system. The molecules generated from this region influence the
antigen presentation to CD4+. The CD4+ is a type of T lymphocyte cell referred to as the Thelper cell, because it releases cytokines, which initiate the body’s response to a perceived threat
or pathogen. This is significant in understanding auto immune disease initiation and progression.
It has a clear relation to SLE, as the body’s inability to recognize its self-antigens is what leads
the immune system to faultily identify itself as a threat and subsequently attack its own tissues
and cellular components.
Hormonal Influences
Estrogen has been identified as one factor that may contribute to the development of SLE
(Lewis et.al. 2017). Lang (2004) reports that while estrogen’s role in the sex differences of SLE
remain unclear, estrogen has been found to have immunomodulatory effects. These effects
extend to regulation of lymphocyte survival and expansion of all T lymphocyte cells (Khan &
Ansar Ahmed, 2016). Much research today has demonstrated that estrogen has the ability to
increase the number of plasma cells, which are responsible for producing antibodies also known
as immunoglobulins (Khan & Ansar Ahmed, 2016). Additionally, estrogen can specifically
enhance the production of autoantibodies. These effects of estrogen account for women during
reproductive years being found to have the highest prevalence of SLE. It also explicates why the
prevalence rates slowly equalize with men as age increases or menopause occurs. This is further
supported by statistical reports of increased onset, exacerbations and worsening symptoms when
estrogen levels are high. These situations may occur naturally through menarche and pregnancy
or artificially through use of oral contraceptives (OC) (Lewis et.al. 2017) (Sanchez‐Guerrero,
Karlson, Liang, Hunter, Speizer, & Colditz, 2005).
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Although, the effect of oral contraceptives has been shown to have a minor effect.
Sanchez‐Guerrero and his colleagues (2005) designed and implemented a prospective cohort
study in which 121,645 women who used oral contraceptives in the past were followed over
fourteen years. The study overall examined the relationship between past OC use and
development of SLE. Specific elements studied with this relationship included the duration of
OC use and the period from first use. No association or correlational relationships were
identified from this data. Although, the researchers overall found and concluded there is a small
but increased risk of developing SLE from past OC use compared to persons who have no OC
use. The study “Shingles, allergies, family medical history, oral contraceptives, and other
potential risk factors for systemic lupus erythematosus” (1994) additionally supported that oral
contraceptives have an “extremely modest” affect in contributing to the development of SLE.
Environmental Influences
As discussed by Molokhia and McKeigue (2005), the contribution of environmental
factors to SLE are not fully understood. Though, past research has identified specific elements
that have been associated with it including the following: ultraviolet light, smoking, stress,
toxins, infections, occupational exposures and certain drugs that increase oxidative stress
(Barbhaiya & Costenbader, 2016). As these are exposures that many people encounter daily,
research suggests that true risk does not occur unless an individual has genetic susceptibility to
SLE (Vaillant, 2020). The susceptibility or predisposition to SLE implicates that an individual
has a set of genetic variations that increase their risk of acquiring the disease by contributing to
its origination but not directly causing it (NIH Genetics Home Reference, 2020). Thus, when
these environmental elements encounter or interact with susceptible genes, the risk for acquiring
SLE increases or activation may occur (Vaillant, 2020).
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More over infections that trigger SLE, they are typically reported as viral. One specific
virus of important mention is the Epstein Barr Virus (EBV). The connection between EBV and
Lupus continues to perplex researches today as it produces an unusual response in comparison to
other viral infections in which the patients have irregular cytokine production as well as impaired
CD8+, which release toxic substances to destroy identified pathogens (James & Robertson,
2012). Overall however, EBV has multiple roles as a potential etiology of SLE and more
research is needed for understanding. Drug induced SLE also has multiple mechanisms that can
be unique to each drug. Approximately 40 medications have been recognized as a potential
trigger of SLE. The most frequently reported include procainamide, hydralazine and quinidine
(Lewis et.al, 2017). Other chemical or toxic exposures include mercury, solvents and pesticides.
These were shown to have significantly contributed to the development of SLE in agricultural
and dental workers. The researchers concluded there is strong association for these occupational
exposures, though did warn that the data may be influenced by a smaller sample size and low
prevalence (Cooper et. al, 2004). Crystalline silica, a common exposure to agricultural workers
has also been identified as a risk factor. It enables SLE development by increasing inflammation
and antibody production ((Parks et al., 2002). Additionally, a study conducted in North Georgia
also revealed environmental pollution as a potential risk factor. Kardestuncer and Frumkin
(1997) examined the prevalence and incidence of lupus in an African-American community that
experienced long term exposure of industrial emissions. The results of the study corroborated
their hypothesis that the prevalence would be higher among that population in comparison to
other communities.
Immunologic Influences
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In normal function, when a cell is damaged it to pursue healing or repairment. In cases
that repairment fails, the cell then initiates a programmed self-destruction, a process known as
apoptosis (Vaillant, 2020). During this process, internal proteins known as self-antigens are
displayed on the surface of the apoptotic cell so that it may be consumed by a mononuclear
phagocyte cell. When the products are not cleared effectively, nucleic acids or proteins are
exposed to the immune system and the body in reaction becomes sensitized to the self-antigens
through B and T lymphocyte activation (Vaillant, 2020). In response, various autoantibodies are
produced such as the Anti-nuclear-antibodies (Lewis et.al. 2017). When the body encounters
these materials again, cytokine release, the complement activation system, and production of
autoantibodies are all stimulated(Vaillant, 2020). Circulating immune complexes then lead to
further tissue and organ damage from the resulting inflammatory processes of complex deposits
in organ membranes and tissues (Lewis et.al. 2017). This inflammatory reaction to the
complexes is considered an immunologic factor that contributes to the development of SLE
because it progresses or advances the state of disease and damage (Midgley)..
Another immunologic factor to highlight as a contributing element to SLE development
is the defective clearance of apoptotic material (Midgley). SLE patients have been found to have a
deficiency of the compliment proteins, specifically C1, C2,C3 and C4, which enable and
promote the macrophages ability to clear apoptotic material effectively (Vaillant, 2020).
Discussion and Summary
Systemic lupus erythematosus is a chronic autoimmune disease, with multisystemic
involvement. The pathophysiology of SLE is suspected to begin with injury to the body’s cells,
consequently resulting in damaged DNA and cellular proteins. This initial damage generally
occurs through any environmental exposures as discussed previously. The environmental risk
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factors are considered the activating factor or trigger of SLE. Genetic predisposition and specific
hormones have a pre and post-affect in which they lower the body’s tolerance to self-antigens
and increase the body’s likelihood of acquiring the disease. The immunologic and hormonal
components interact in unclear pathways today to sustain and potentially advance the disease
condition. While exact patterns and the extent of each etiological category have not been defined
in their contribution to SLE development, researchers have identified the interactions among the
four primary etiologies and the pursuit of understanding for these etiologies remains vastly
unwavering. The results of studies revealed that upon further investigation, gene therapy and
correction of immune deficiencies are potential prophylactic therapies.
Limitations of this literature review include lack of similarity between all procedural and
design methods; lack of a unanimous standard of information provided in addition to small
sample sizes, varying age ranges, and lack of repetition for these studies to verify results.
Another considerable limitation of the studies appeared to be the lack of assessment for the
extent of exposure to risk factors and the total summation of risk factors pre-diagnosis. Further
research should explore these elements and continue to investigate the patterns in which these
etiological categories interact to develop SLE.
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